News

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over“Deceptive” Marketing Of Wegovy Hagens Berman
The lawsuits follow an announcement by Novo Nordisk that it terminated its collaboration with the telehealth company due to concerns about Hims & Hers' sales and“deceptive” marketing of the weight ...
Investing.com India57m
Hims CEO reveals details of Novo Nordisk partnership breakdown - WaPo
Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses On Their Investment In Hims & Hers Health, Inc. Of Class Action Lawsuit And Upcoming Deadlines - HIMS
On this news, Hims & Hers' stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.
Managed Healthcare Executive42m
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...